US Supplement Market Regulation: Depression Claim, Undisclosed Drug, COVID Tincture
Executive Summary
FDA warns 10 businesses they’re marketing unapproved and misbranded drugs by making claims for supplements to treat depression. Supplement also found with one of, if not the most common violations in the US supplement market: it contained an undisclosed ED drug.
You may also be interested in...
COVID-19 Stress Drives Anxiety-Reducing Supplement Sales Up 79% In US Since 2018
Sales for anxiety/stress relief dietary supplements in 2020 grew 79% from 2018, eclipsing growth of 22% for general herbal supplements during the same comparison period. Stress-relief supplements including St. John’s wart, ashwagandha and cannabinoids continue to grow in popularity.
More ED-Spiked Supplements Sold On Amazon Recalled Following US FDA Tests
US FDA published announcement by two firms recalling products they sold under the brand Thumbs Up 7 and that were found in FDA tests to contain undeclared sildenafil and tadalafil.
US FDA Concern Rekindled After Finding ED-Spiked Supplements Sold On Amazon
NJ firms S&B Shopper and Namoo Enterprise recall products after FDA tests found undisclosed erectile dysfunction drugs sildenafil and tadalafil. FDA officials Imperial Extreme 2000 and Namoo’s PremierZen Black 5000 capsules on Amazon.